These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37239041)

  • 1. The Role of NETosis and Complement Activation in COVID-19-Associated Coagulopathies.
    Ghanbari EP; Jakobs K; Puccini M; Reinshagen L; Friebel J; Haghikia A; Kränkel N; Landmesser U; Rauch-Kröhnert U
    Biomedicines; 2023 May; 11(5):. PubMed ID: 37239041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19.
    Puccini M; Jakobs K; Reinshagen L; Friebel J; Schencke PA; Ghanbari E; Landmesser U; Haghikia A; Kränkel N; Rauch U
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of surface neutrophilic MPO expression level in NETosis and NETosis-associated coagulopathies in covid-19 infected patients.
    Jamali E; Abbasi M; Tayer AH; Monfared AA; Tandel P; Tamaddon G; Kazerooni ES; Rakhshandehroo S; Ranjbaran R
    Blood Cells Mol Dis; 2022 May; 96():102676. PubMed ID: 35661911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NETosis induction reflects COVID-19 severity and long COVID: insights from a 2-center patient cohort study in Israel.
    Krinsky N; Sizikov S; Nissim S; Dror A; Sas A; Prinz H; Pri-Or E; Perek S; Raz-Pasteur A; Lejbkowicz I; Cohen-Matsliah SI; Almog R; Chen N; Kurd R; Jarjou'i A; Rokach A; Ben-Chetrit E; Schroeder A; Caulin AF; Yost CC; Schiffman JD; Goldfeder M; Martinod K
    J Thromb Haemost; 2023 Sep; 21(9):2569-2584. PubMed ID: 37054916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of transcriptomic data sets supports the role of IL-6 in NETosis and immunothrombosis in severe COVID-19.
    Mukhopadhyay S; Sinha S; Mohapatra SK
    BMC Genom Data; 2021 Nov; 22(1):49. PubMed ID: 34775962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Inflammation and Complement Activation Parameters Predict Clinical Outcome of Severe SARS-CoV-2 Infections.
    Huber S; Massri M; Grasse M; Fleischer V; Kellnerová S; Harpf V; Knabl L; Knabl L; Heiner T; Kummann M; Neurauter M; Rambach G; Speth C; Würzner R
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of autoinflammation as a principal mechanism of myocardial injury in SARS-CoV-2 PCR-positive medical examiner cases.
    Hammond ME; Christensen ED; Belenky M; Snow GL; Shah K; Hammond MEH
    Diagn Pathol; 2023 Oct; 18(1):114. PubMed ID: 37853435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NETosis and Neutrophil Extracellular Traps in COVID-19: Immunothrombosis and Beyond.
    Zhu Y; Chen X; Liu X
    Front Immunol; 2022; 13():838011. PubMed ID: 35309344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response.
    Jayarangaiah A; Kariyanna PT; Chen X; Jayarangaiah A; Kumar A
    Clin Appl Thromb Hemost; 2020; 26():1076029620943293. PubMed ID: 32735131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NETosis and SARS-COV-2 infection related thrombosis: a narrative review.
    Behzadifard M; Soleimani M
    Thromb J; 2022 Mar; 20(1):13. PubMed ID: 35354492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy.
    Nicolai L; Leunig A; Brambs S; Kaiser R; Weinberger T; Weigand M; Muenchhoff M; Hellmuth JC; Ledderose S; Schulz H; Scherer C; Rudelius M; Zoller M; Höchter D; Keppler O; Teupser D; Zwißler B; von Bergwelt-Baildon M; Kääb S; Massberg S; Pekayvaz K; Stark K
    Circulation; 2020 Sep; 142(12):1176-1189. PubMed ID: 32755393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation.
    Jakobs K; Reinshagen L; Puccini M; Friebel J; Wilde AB; Alsheik A; Rroku A; Landmesser U; Haghikia A; Kränkel N; Rauch-Kröhnert U
    Front Immunol; 2022; 13():844701. PubMed ID: 35359931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prospective Study of Specialized Coagulation Parameters in Admitted COVID-19 Patients and Their Correlation With Acute Respiratory Distress Syndrome and Outcome.
    Sehgal T; Gupta N; Kohli S; Khurana A; Dass J; Diwan S; A J M; Khan M; Aggarwal M; Subramanian A
    Cureus; 2021 Aug; 13(8):e17463. PubMed ID: 34589359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality.
    Sinkovits G; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Mező B; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
    Thromb Haemost; 2022 Feb; 122(2):240-256. PubMed ID: 35062036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct blood fluorescence signal intensity of neutrophils (NEU-SFL): A predictive marker of death in hospitalized COVID-19 patients?
    Fortier M; Chea M; Aïn C; Loyens M; Boudemaghe T; Gris JC; Bouvier S
    Front Med (Lausanne); 2022; 9():1062112. PubMed ID: 36619613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement Activation in Kidneys of Patients With COVID-19.
    Pfister F; Vonbrunn E; Ries T; Jäck HM; Überla K; Lochnit G; Sheriff A; Herrmann M; Büttner-Herold M; Amann K; Daniel C
    Front Immunol; 2020; 11():594849. PubMed ID: 33584662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection.
    Sinkovits G; Mező B; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
    Front Immunol; 2021; 12():663187. PubMed ID: 33841446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum citrullinated histone H3 levels in COVID-19 patients with acute ischemic stroke.
    Bayar MD; Şişman AB; Koral G; Çirak S; Tüzün E; Günaydin S; Baştan B
    Ideggyogy Sz; 2022 May; 75(5-06):191-198. PubMed ID: 35819341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.
    Goshua G; Pine AB; Meizlish ML; Chang CH; Zhang H; Bahel P; Baluha A; Bar N; Bona RD; Burns AJ; Dela Cruz CS; Dumont A; Halene S; Hwa J; Koff J; Menninger H; Neparidze N; Price C; Siner JM; Tormey C; Rinder HM; Chun HJ; Lee AI
    Lancet Haematol; 2020 Aug; 7(8):e575-e582. PubMed ID: 32619411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.